The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Colinz Laboratories Ltd

Colinz Laboratories Ltd

BSE 531210 · NSE COLINZ · ISIN INE923C01011 · Group XT · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹74.77

+3.12%

BSE close, 28 August 2026

Market cap

₹18.84 cr

0.3 cr shares · Micro cap

Free float

₹6.40 cr

as published

P/E · P/B

6.7× · 2.02×

EPS ₹11.10 · BV ₹37.01

FY25-26 rev / PAT

6.14 / 0.52

₹ cr, as filed

Filings, window

18

4 selected · 22%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹36.11 52-WK HIGH ₹87.91 ₹74.77 75% of range
Against 52-week high-14.9%
Against 52-week low+107.1%
Day change+3.12%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹11.10
Price / earnings6.74×
Price / book2.02×
Book value — derived, price ÷ P/B₹37.01
Return on equity29.93%
Operating margin237.47%
Net margin193.47%

Consistency check

P/B ÷ P/E, which must equal ROE
29.97%
ROE as published
29.93%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 1.24 2.40 9.53 237.47% 193.47%
Mar-26 · Q 1.75 0.17 0.68 15.22% 9.78%
FY25-26 6.14 0.52 2.04 14.54% 8.39%

Quarter on quarter

Revenue, quarter on quarter
-29.1%
Net profit, quarter on quarter
+1,311.8%
Operating margin, quarter on quarter
+22,225 bps

Disclosure profile 18 filings in the window

0 median 17.0 p75 · 25 sector max 52 18 54th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Open Offer2
Board Outcome1
Results1
Selected sub-total4
Procedural
General4
AGM / EGM3
Newspaper Publication3
Annual Report1
Book Closure1
Compliance Certificate1
Trading Window1
Procedural sub-total14
Total18

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group XT, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

18 filings · 4 selected · busiest 2026-08-20

Filing rhythm · the twelve most recent

2026-08-122026-10-07

SelectedProcedural

Filings

18 in the window · 8 earlier on record

  1. 7 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Dear Sir, PFA, The Compliance Certificate issued by our RTA for Sep-26 under regulation 74(5). Kindly take the same on records . For Colinz Labs Ltd Director

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 1 October 2026 ·

    General

    Declaration Of Non-Applicability Of Reg. 32 Of The SEBI (LODR) Regulations, 2015 (Statement Of Deviation Or Variation For Proceeds Of Public Issue, Rights Issue, Preferential Issue, QIP) For The Quarter Ended 30.09.2026.

    Dear Sir, PFA, attached Certificate under Regulation 32 of SEBI(LODR) Regulation,2015 and Statement of Deviation or Variation is NOT applicable to the Company for the Quarter Ended on ....

    Company Update / General View filing →

  3. 1 October 2026 ·

    General

    Declaration With Respect To Non-Applicability Of Related Party Transactions Pursuant To Regulations 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements, Regulation 2015).

    Dear Sir, Pursuant to Regulations23(9) of SEBI (LODR). Regulations,2015, the said Regulation is not applicable to us, Kindly take the Non-Applicability Certificate on records for Quarter ....

    Company Update / General View filing →

  4. 29 September 2026 ·

    Trading Window

    Closure of Trading Window

    We would like to inform you that pursuant to the COmpanys Act and SEBI(PIT), Regulation, 2015 The Trading Window for Designated Persons and KMPS will remain closed form 1-10-26 to till ....

    Insider Trading / SAST / Closure of Trading Window View filing →

  5. 23 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Please find enclosed herewith the Srutinizers Report for our 40th AGM held on 22-09-2026 issued todted dated 23-09-2026. Kindly take the same on records. For Colinz Labs Ltd Director

    AGM/EGM / AGM View filing →

  6. 22 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    DEAR SIR SUMMERY OF OF 40TH AGM HELD ON 22-09-2026 AT 2.30 PM . KINDLY TAKE THE SAME ON RECORDS FOR COLINZ LABORATORIES LTD VIJAYA MANI CHAIRPESRSON OF THE MEETING

    AGM/EGM / AGM View filing →

  7. 4 September 2026 ·

    General

    Post Offer Advertisement

    Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Post Offer Advertisement under Regulation 18(12) of The Securities and Exchange Board of India ....

    Company Update / General View filing →

  8. 27 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Dear Sir, Pursuant to Regualtion 47 of SEBI(LODR) Regulations, 2015 we ahereby enclosed News Papar Cliping of our 40 th AGM Ads given in the Paper on 27-08-2026. Kindly take the same ....

    Company Update / Newspaper Publication View filing →

  9. 20 August 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Dear Sir, Pursuant to Regulation 34(1) and Regulation 30 of SEBI(LODR),Regulations ,2015. Please find the attached our 40th Annual Report for the FY 2025-26. Kindly take the same on ....

    Others / Reg. 34 (1) Annual Report View filing →

  10. 20 August 2026 ·

    Book Closure

    Notice Of Book Closure Under Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements), 2015 & E-Voting Schedule

    Dear Sir, AS requied under Regulation 42 of SEBI(LODR) , Regulations, 2015 we are submitting herewith the Intimation towards closure of Book from 15-09-2026 to 22-09-2026 for the purpose ....

    Corp. Action / Book Closure View filing →

  11. 20 August 2026 ·

    AGM / EGM

    Notice Of 40Th AGM And Book Closure.

    As required under SEBI (LODR)Regulaions, 2015 and Section 108 Companies Act 2013 Reas with Rule 20 and other Applicable Rules thereunder, we are submitting herewith 40th AGM Notice of our ....

    AGM/EGM / AGM View filing →

  12. 12 August 2026 ·

    Open Offer

    Updates on Open Offer

    Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Reminder Advertisement dated August 11, 2026 in relation to the open offer of Colinz Laboratories ....

    Company Update / Open Offer View filing →

  13. 6 August 2026 ·

    Open Offer

    Updates on Open Offer

    Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of offer opening public announcement under Regulation 18(7) of the SEBI (SAST) Regulations, 2011, ....

    Company Update / Open Offer View filing →

  14. 5 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Dear Sir, Submitting herewith the News Paper Clipping towards Advertiement in Newspaper towards submission of Declaration of Independent Directors Under SEBI SAST Regulation ,2011 and ....

    Company Update / Newspaper Publication View filing →

  15. 31 July 2026 ·

    General

    Letter of Offer

    Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Public Shareholders of Colinz Laboratories Ltd ("Target ....

    Company Update / General View filing →

  16. 31 July 2026 ·

    Newspaper Publication

    Newspaper Publication

    Dear Sir, As required under SEBI(LODR), Regulation, 2015, we are submitting herewith the News Paper Publication , published on 31-7-2026 for the Quarter Ended 30-6-2026. Kindly take ....

    Company Update / Newspaper Publication View filing →

  17. 30 July 2026 ·

    Results

    Outcome Of The Meeting Of Board Of Directors Was Held On Thursday, 30Th July, 2026 At 03:30 P.M. The Board Of Directors Discussed And/Or Approved The Following

    Please find the attached OUTCOME of the meeting held today dated 30-07-2026 the details of the approved agenda are shown in the OUTCOME.

    Result / Financial Results View filing →

  18. 30 July 2026 ·

    Board Outcome

    Board Meeting Outcome for OUTCOME Of The Meeting Of Board Of Directors Was Held On Thursday, 30Th July, 2026 At 03:30 P.M. The Board Of Directors Discussed And/Or Approved The Following

    1. The Board considered and approved Un-Audited Financial Results for the quarter ended 30th June, 2026 as per Regulation 33 (3) of SEBI (Listing Obligations and Disclosure Requirements) ....

    Board Meeting / Outcome of Board Meeting View filing →

RSS feed for Colinz Laboratories Ltd · the 50 most recent filings